The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN.
Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835.
Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.
Elbarbary NS, Ismail EAR, Mohamed SA.
Clin Nutr. 2023 Dec;42(12):2372-2380. doi: 10.1016/j.clnu.2023.10.007. Epub 2023 Oct 13.
The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis.
Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P.
J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001435.
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies.
Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, Huang L, Liu Y.
Signal Transduct Target Ther. 2023 Apr 10;8(1):152. doi: 10.1038/s41392-023-01400-z.
Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.
Elfaki I, Mir R, Almutairi FM, Duhier FMA.
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070. doi: 10.22034/APJCP.2018.19.8.2057.
Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Wang P, Xu YY, Lv TT, Guan SY, Li XM, Li XP, Pan HF.
Angiology. 2019 Feb;70(2):141-159. doi: 10.1177/0003319718787366. Epub 2018 Jul 15.
Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus.
Tang N, Jiang S, Yang Y, Liu S, Ponnusamy M, Xin H, Yu T.
Cardiovasc Ther. 2018 Aug;36(4):e12436. doi: 10.1111/1755-5922.12436. Epub 2018 Jun 28.
Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications.
Zhu Y, Xia X, He Q, Xiao QA, Wang D, Huang M, Zhang X.
Front Endocrinol (Lausanne). 2023 Aug 3;14:1202463. doi: 10.3389/fendo.2023.1202463. eCollection 2023.
[Atherosclerosis in patients with type 1 diabetes].
Karásek D.
Vnitr Lek. 2020 Winter;65(12):775-782.
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.
Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S.
Int J Biol Sci. 2021 May 11;17(8):2050-2068. doi: 10.7150/ijbs.59965. eCollection 2021.
